Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Sumazaki

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Cancer|September 1, 1995
Successful treatment of invasive thoracopulmonary mucormycosis in a patient with acute lymphoblastic leukemiaT Fukushima, R Sumazaki, M Shibasaki, et al.
Human Pathology|October 1, 1993
A case of fatal infectious mononucleosis presenting with fulminant hepatic failure associated with an extensive CD8-positive lymphocyte infiltration in the liverY Tazawa, F Nishinomiya, H Noguchi, et al.
The Pharmacogenomics Journal|November 19, 2014
Multidrug resistance protein 4 (MRP4) polymorphisms impact the 6-mercaptopurine dose tolerance during maintenance therapy in Japanese childhood acute lymphoblastic leukemiaY Tanaka, A Manabe, H Fukushima, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Cancer|September 1, 1995
Successful treatment of invasive thoracopulmonary mucormycosis in a patient with acute lymphoblastic leukemiaT Fukushima, R Sumazaki, M Shibasaki, et al.
Human Pathology|October 1, 1993
A case of fatal infectious mononucleosis presenting with fulminant hepatic failure associated with an extensive CD8-positive lymphocyte infiltration in the liverY Tazawa, F Nishinomiya, H Noguchi, et al.
The Pharmacogenomics Journal|November 19, 2014
Multidrug resistance protein 4 (MRP4) polymorphisms impact the 6-mercaptopurine dose tolerance during maintenance therapy in Japanese childhood acute lymphoblastic leukemiaY Tanaka, A Manabe, H Fukushima, et al.
Pageof 4